ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,793Medicare Part D Prescriptions Filled, Including Refills

Rank: 346 out of 1000

$349K Total Retail Price of All Prescriptions

Rank: 399 out of 1000

902 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 902 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 5,778 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
POTASSIUM CHLORIDE 269 229 1 10
SIMVASTATIN 267 209 2 3
FUROSEMIDE 257 229 3 7
AMLODIPINE BESYLATE 217 171 4 6
CARVEDILOL 202 155 5 15
LEVOTHYROXINE SODIUM 186 136 6 4
OMEPRAZOLE 173 106 7 2
HYDROCHLOROTHIAZIDE 135 107 8 9
CLONIDINE HCL 133 120 9 27
METOPROLOL TARTRATE 125 114 10 19
ATORVASTATIN CALCIUM 119 104 11 18
CITALOPRAM HBR 109 94 12 17
HYDROCODONE-ACETAMINOPHEN 108 67 S3 13 1
METFORMIN HCL 108 71 13 8
PANTOPRAZOLE SODIUM 106 102 15 28
GABAPENTIN 104 77 16 11
LISINOPRIL 100 64 17 5
PLAVIX 97 89 18 49
AZITHROMYCIN 89 36 19 36
ATENOLOL 84 56 20 24
SERTRALINE HCL 76 43 21 26
NEXIUM 74 31 22 23
PRAVASTATIN SODIUM 74 64 22 12
DONEPEZIL HCL 73 73 24 32
RANITIDINE HCL 73 45 24 37
TIZANIDINE HCL 73 35 24 76
WARFARIN SODIUM 72 69 27 22
LOVASTATIN 71 65 28 41
RAMIPRIL 71 51 28 77
ROPINIROLE HCL 68 51 30 82
LOSARTAN POTASSIUM 65 56 31 25
DIVALPROEX SODIUM 63 62 32 113
LANTUS 62 35 33 68
TRAZODONE HCL 58 31 34 29
HUMULIN N 56 45 35 302
CLOPIDOGREL 56 45 35 35
HUMULIN 70-30 56 34 35 131
DIGOXIN 54 54 38 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 36 39 20
CEPHALEXIN 51 30 40 90
AMLODIPINE BESYLATE-BENAZEPRIL 50 38 41 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.